Skip to main content
SpringerLink
Log in

Clinical and Cost Effectiveness of Neuromodulation Devices in the Treatment of Headaches: Focus on Non-invasive Therapies

  • Chapter
  • First Online:
Neuromodulation in Headache and Facial Pain Management

Part of the book series: Headache ((HEAD))

Abstract

Primary headaches are a common indication for review in neurology clinics. Migraines, tension-type headaches and trigeminal-autonomic cephalalgia (TAC) are the most common primary headache disorders. Migraines can cause significant functional disability and cluster headaches (the commonest TAC) are one of the worst pains known to mankind. Pharmacological treatment has been the standard for both abortive and prophylactic intervention for many years, but there are patients who are refractory to medical therapy and there are others who cannot take such medications because of co-morbidities or cannot tolerate the side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. NICE. NICE. How NICE measures value for money in relation to public health interventions. 2013. www.nice.org.uk/Media/Default/guidance/LGB10-Briefing-20150126.pdf

  2. Bruggenjurgen B, Baker T, Bhogal R, Ahmed F. Cost impact of an non-invasive, portable device for patient self-administration of chronic migraine in a UK National Health Service setting. Springerplus. 2016;5:1249.

    Article  CAS  Google Scholar 

  3. Morris J, Straube A, Diener H-C, Ahmed F, Silver N, Walker S, et al. Cost-effectiveness analysis of non-invasive vagus nerve stimulation for the treatment of chronic cluster headache. J Headache Pain. 2016;17(1):43.

    Article  Google Scholar 

  4. Dodick DW, Turkel CC, Degryse RE, Aurora SK, Silberstein SD, Lipton RB, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT Clinical Program. Headache. 2010;50(6):921–36.

    Article  Google Scholar 

  5. NICE TAG. NICE. Botulinum toxin type A for the prevention of headaches in adults with chronic migraine. Technology appraisal guidance [TA260]. 2012. https://www.nice.org.uk/guidance/ta260/resources/botulinum-toxin-typea-for-the-prevention-of-headaches-in-adults-with-chronic-migraine-pdf-82600545273541

  6. Bhola R, Kinsella E, et al. Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program. J Headache Pain. 2015;16:535.

    Google Scholar 

  7. Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Pearlman SH, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol. 2010;9(4):373–80.

    Article  Google Scholar 

  8. Starling AJ, et al. A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study). Cephalalgia. 2018;38(6):1038–48. https://doi.org/10.1177/0333102418762525.

    Article  Google Scholar 

  9. Brighina F, Piazza A, Vitello G, Aloisio A, Palermo A, Daniele O, Fierro B. rTMS of the prefrontal cortex in the treatment of chronic migraine: a pilot study. J Neurol Sci. 2004;227(1):67–71.

    Article  Google Scholar 

  10. Teepker M, Hötzel J, Timmesfeld N, Reis J, Mylius V, Haag A, et al. Low-frequency rTMS of the vertex in the prophylactic treatment of migraine. Cephalalgia. 2010;30(2):137–44.

    Article  CAS  Google Scholar 

  11. Misra UK, Kalita J, Bhoi SK. High-rate repetitive transcranial magnetic stimulation in migraine prophylaxis: a randomized, placebo-controlled study. J Neurol. 2013;260(11):2793–801.

    Article  Google Scholar 

  12. Conforto AB, Amaro E Jr, et al. Randomized, proof-of-principle clinical trial of active transcranial magnetic stimulation in chronic migraine. Cephalalgia. 2014;34:464–72.

    Article  Google Scholar 

  13. Kalita J, Laskar S, et al. Efficacy of single versus three sessions of high rate repetitive transcranial magnetic stimulation in chronic migraine and tension-type headache. J Neurol. 2016;263:2238–46.

    Article  Google Scholar 

  14. Shehata HS, Esmail E-J, et al. Repetitive transcranial magnetic stimulation versus botulinum toxin injection in chronic migraine prophylaxis: a pilot randomized trial. J Pain Res. 2016;9:771–7.

    Article  CAS  Google Scholar 

  15. Silberstein S, Calhoun A, Lipton R, Grosberg B, Cady R, Dorlas S, et al. Chronic migraine headache prevention with noninvastive vagus nerve stimulation. The EVENT study. Neurology. 2016;87:529–38.

    Article  Google Scholar 

  16. Gaul C, Magis D, Liebler E, Straube A. Effects of non-invasive vagus nerve stimulation on attack frequency over time and expanded response rates in patients with chronic cluster headache: a post hoc analysis of the randomised, controlled PREVA study. J Headache Pain. 2017;18(1):22.

    Article  Google Scholar 

  17. Nesbitt A, Marin J, Tompkins E, Ruttledge M, Goadsby P. Initial use of a novel noninvasive vagus nerve stimulator for cluster headache treatment. Neurology. 2015;84:1249–53.

    Article  CAS  Google Scholar 

  18. Gaul C, Diener H-C, Silver N, Magis D, Reuter U, Andersson A, et al. Non-invasive vagus nerve stimulation for PREVention and acute treatment of chronic cluster headache (PREVA): a randomised controlled study. Cephalalgia. 2016;36(6):534–46.

    Article  Google Scholar 

  19. Silberstein S, Mechtler L, Kudrow D, Calhoun A, McClure C, Sapper J, et al. Non-invasive vagus nerve stimulation for the Acute treatment of cluster headache: findings from the randomized, double-blind, sham-controlled ACT1 study. Headache. 2016;56:1317–32.

    Article  Google Scholar 

  20. Goadsby P, de Coo I, Silver N, Tyagi A, Ahmed F, Gaul C, et al. Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: a randomized, double-blind, sham-controlled ACT2 study. Cephalalgia. 2018;38(5):959–69.

    Article  Google Scholar 

  21. Goadsby P, Grosberg B, Mauskop A, Cady P, Simmons K. Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study. Cephalalgia. 2014;34(12):986–93.

    Article  CAS  Google Scholar 

  22. Kinfe T, Pintea B, Muhammad S, Zaremba S, Roeske S, Simon B, Vatter H. Cervical non-invasive vagus nerve stimulation (nVNS) for preventative and acute treatment of episodic and chronic migrain and migraine-associated sleep disturbance: preliminary findings from a prospective observational cohort study. J Headache Pain. 2015;16:101.

    Article  Google Scholar 

  23. Barbanti P, Grazzi L, Egeo G, Padovan A, Liebler E, Bussone G. Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open label study. J Headache Pain. 2015;16:61.

    Article  Google Scholar 

  24. Straube A, Ellrich J, Eren O, Blum B, Ruscheweyh R. Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial. J Headache Pain. 2015;16(1):63.

    Article  Google Scholar 

  25. Grazzi L, Egeo G, Calhoun AH, McClure C, Liebler E, Barbanti P. Non-invasive Vagus nerve stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study. J Headache Pain. 2016;17(1):91.

    Article  Google Scholar 

  26. Schoenen J, Vandermissen B, Jeangette S, Herroelen L, Vandenheede M, Gerald P, Magis D. Migraine prevention with a supraorbital transcutaenous stimulator: a randomized controlled trial. Neurology. 2013;80:697–704.

    Article  Google Scholar 

  27. Magis D, Sava S, d’Elia TS, Baschi R, Schoenen J. Safety and patients’ satisfaction of transcutaneous supraorbital neurostimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population. J Headache Pain. 2013;14(1):95.

    Article  Google Scholar 

  28. Di Fiore P, Bussone G, Galli A, Didier H, Peccarisi C, D’Amico D, Frediani F. Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open label preliminary trial. Neurol Sci. 2017;38:201–6.

    Article  Google Scholar 

  29. Russo A, Tessitore A, Conte F, Marcuccio L, Giordano A, Tedeschi G. Transcutaneous supraorbital neurostimulation in ‘de novo’ patients with migraine without aura: the first Italian experience. J Headache Pain. 2015;16:69.

    Article  Google Scholar 

  30. Vikelis M, Dermitzakis E, Spingos K, Vasiliadis G, Vlachos G, Kararizou E. Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical study. BMC Neurol. 2017;17:97.

    Article  Google Scholar 

  31. Riederer F, Penning S, Schoenen J. Transcutaneous supraorbital nerve stimulation (t-SNS) with the Cefaly device for migraine prevention: a review of the available data. Pain Therapy. 2015;4:135–47.

    Article  Google Scholar 

  32. Miller S, Sinclair A, Davies B, Matharu M. Neurostimulation in the treatment of primary headaches. Pract Neurol. 2016;16:362–75.

    Article  Google Scholar 

  33. Bussone G, Diener H-C, Pfeil J, Schwalen S. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Int J Clin Pract. 2005;59(8):961–8.

    Article  CAS  Google Scholar 

  34. Mulleners W, Chronicle EP. Anticonvulsants in migraine prophylaxis: a Cochrane review. Cephalalgia. 2008;28(6):585–97.

    Article  CAS  Google Scholar 

  35. Linde K, Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Database Syst Rev. 2004;2:CD003225. https://doi.org/10.1002/14651858.CD003225.pub2.

Download references

Author information

Authors and Affiliations

  1. Department of Neurosciences, Hull York Medical School, Hull, UK

    Ho Tin Wong & Fayyaz Ahmed

Authors
  1. Ho Tin Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fayyaz Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fayyaz Ahmed .

Editor information

Editors and Affiliations

  1. Headache Centre, Guy’s and St Thomas’, NHS Foundation Trust, Pain Management and Neuromodulation Centre and Neurology Department, London, UK

    Giorgio Lambru

  2. Department de Traitement de la douleur, Centre Hospitalier Universitaire de Nice, Department de Traitement de la douleur, Nice, France

    Michel Lanteri-Minet

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wong, H.T., Ahmed, F. (2020). Clinical and Cost Effectiveness of Neuromodulation Devices in the Treatment of Headaches: Focus on Non-invasive Therapies. In: Lambru, G., Lanteri-Minet, M. (eds) Neuromodulation in Headache and Facial Pain Management. Headache. Springer, Cham. https://doi.org/10.1007/978-3-030-14121-9_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-14121-9_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-14120-2

  • Online ISBN: 978-3-030-14121-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation